Similar articles for PMID: 29257735

Year	Number of Results
2003	1
2008	1
2009	1
2011	2
2012	3
2013	6
2014	11
2015	22
2016	13
2017	20
2018	15
2019	14
2020	14
2021	18
2022	12
2023	5
2024	0

1

Cardiac amyloidosis: An update on diagnosis and treatment.

Donnelly JP, Hanna M. Donnelly JP, et al. Cleve Clin J Med. 2017 Dec;84(12 Suppl 3):12-26. doi: 10.3949/ccjm.84.s3.02. Cleve Clin J Med. 2017. PMID: 29257735 Free article. Review.

2

[The Changing Appearance of Cardiac Amyloidosis].

Mahrholdt H, Klingel K, Sechtem U. Mahrholdt H, et al. Dtsch Med Wochenschr. 2018 Sep;143(18):1335-1343. doi: 10.1055/s-0043-109420. Epub 2018 Sep 10. Dtsch Med Wochenschr. 2018. PMID: 30199915 Review. German.

3

Cardiac Amyloidosis Treatment.

Stern LK, Patel J. Stern LK, et al. Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):59-72. doi: 10.14797/mdcvj.1050. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35414852 Free PMC article. Review.

4

Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.

Adam RD, Coriu D, Jercan A, Bădeliţă S, Popescu BA, Damy T, Jurcuţ R. Adam RD, et al. ESC Heart Fail. 2021 Aug;8(4):2380-2396. doi: 10.1002/ehf2.13443. Epub 2021 Jun 5. ESC Heart Fail. 2021. PMID: 34089308 Free PMC article. Review.

5

Transthyretin Cardiac Amyloidosis in Older Americans.

Brunjes DL, Castano A, Clemons A, Rubin J, Maurer MS. Brunjes DL, et al. J Card Fail. 2016 Dec;22(12):996-1003. doi: 10.1016/j.cardfail.2016.10.008. Epub 2016 Oct 18. J Card Fail. 2016. PMID: 27769906 Free PMC article. Review.

6

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.

Galant NJ, Westermark P, Higaki JN, Chakrabartty A. Galant NJ, et al. Clin Sci (Lond). 2017 Mar 1;131(5):395-409. doi: 10.1042/CS20160413. Clin Sci (Lond). 2017. PMID: 28213611 Review.

7

Unfolding Cardiac Amyloidosis -From Pathophysiology to Cure.

Ablasser K, Verheyen N, Glantschnig T, Agnetti G, Rainer PP. Ablasser K, et al. Curr Med Chem. 2019;26(16):2865-2878. doi: 10.2174/0929867325666180104153338. Curr Med Chem. 2019. PMID: 29303069 Review.

8

Cardiac amyloidosis: updates in diagnosis and management.

Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A. Mohty D, et al. Arch Cardiovasc Dis. 2013 Oct;106(10):528-40. doi: 10.1016/j.acvd.2013.06.051. Epub 2013 Sep 23. Arch Cardiovasc Dis. 2013. PMID: 24070600 Free article. Review.

9

Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.

Griffin JM, Maurer MS. Griffin JM, et al. Trends Cardiovasc Med. 2021 Jan;31(1):59-66. doi: 10.1016/j.tcm.2019.12.003. Epub 2019 Dec 17. Trends Cardiovasc Med. 2021. PMID: 31889610 Free PMC article. Review.

10

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Maurer MS, et al. Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4. Circ Heart Fail. 2019. PMID: 31480867 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year